Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease marked by irreversible fibrosis and poor prognosis. Growing disease awareness and improved diagnostics are expanding the ...

Roche has waved goodbye to an inflammation drug from Kiniksa Pharmaceuticals—as well as the $100 million that the pharma paid for the therapy—as part of a ...

Announcing a new article publication for BIO Integration journal. Cardiac cell death and myocardial fibrosis after ischemia-reperfusion (I/R) injury are the primary causes of impaired cardiac function ...

Novel non-invasive liver disease assessments (NILDAs) are effective alternatives to liver biopsy for the treatment of liver ...

Targeted therapies for MASH show progress, with pegozafermin leading in efficacy for fibrosis regression and disease resolution. New research highlights the effectiveness of targeted therapies for ...

When UNSW Associate Professor Shafagh Waters explains cystic fibrosis (CF) to the children she works with, she asks them to ...

Dr. Shune concludes the discussion by focusing on safety, sequencing, and practical considerations for incorporating ...

In this Q&A, Avitzur breaks down the study’s findings and suggests how the information can be used to advance PF research and treatments. This transcript has been lightly edited for clarity. AJMC: ...

Care for patients with cystic fibrosis has undergone transformative changes over the past decade and serves as an example of how an understanding of the functional consequences of a genetic disease ...

Clark Grady has cystic fibrosis. It hasn't stopped him from playing sports and taking the disease head on as a fundraiser.